ReThink Medical is a medical device and digital health company developing a wrist-worn monitoring device.
Our technology is designed to predict and prevent heart failure hospitalizations through compliance-centric continuous physiologic monitoring & machine learning.
Our product, CorBand™ uses state of the art algorithms and artificial intelligence to potentially detect worsening conditions weeks in advance - even before noticeable symptoms.
Data-driven therapy can allow ample time for proper treatment to prevent hospitalization, improve quality of life, and save billions in healthcare costs.
We've designed a proactive approach to managing heart failure patients with a focus on compliance, simplicity, and accuracy.
Our technology is designed to predict and prevent heart failure hospitalizations through compliance-centric continuous physiologic monitoring & machine learning.
Our product, CorBand™ uses state of the art algorithms and artificial intelligence to potentially detect worsening conditions weeks in advance - even before noticeable symptoms.
Data-driven therapy can allow ample time for proper treatment to prevent hospitalization, improve quality of life, and save billions in healthcare costs.
We've designed a proactive approach to managing heart failure patients with a focus on compliance, simplicity, and accuracy.
Location: United States, California, San Francisco
Employees: 11-50
Total raised: $3.5M
Investors 3
Funding Rounds 1
| Date | Series | Amount | Investors |
| 03.05.2017 | Series A | $3.5M | Emergent M... |
Mentions in press and media 6
| Date | Title | Description |
| 03.05.2017 | ReThink Medical raises $3 million for a wearable device to predict heart failure | San Francisco-based ReThink Medical raised $3 million to develop a medical wearable to predict and prevent heart failure. The round was led by Emergent Medical with additional funding from Norwich Ventures and Launch Capital. The company is... |
| 02.05.2017 | Term Sheet — Tuesday, May 2 | PUTTING THE SILICON IN SILICON VALLEY Today we have another installment in Term Sheet’s series of interviews with dealmakers at the tech industry’s most active acquirers. Cisco is an acquisition machine, having done nearly 200 deals in its ... |
| 01.05.2017 | ReThink Medical Raises $3M Series A | SAN FRANCISCO, CA, Leading data-driven heart failure medical device and digital health company, announced today a Series A investment of $3 million. >> Click here for more funding data on ReThink Medical >> To export ReThink... |
| 01.05.2017 | ReThink Medical Raises $3M in Series A Funding | ReThink Medical, a San Francisco, CA-based data-driven heart failure medical device and digital health company, raised $3m in Series A funding. The round, which added to the two National Institutes of Health (NIH) grants and a strategic par... |
| 01.05.2017 | Launch Capital Joins $3M Series A for ReThink Medical | ReThink Medical, a leading data-driven heart failure medical device and digital health company, announced today a Series A investment of $3 million led by medical device equity firm Emergent Medical Partners (EMP). EMP will lead the round w... |
| 01.05.2017 | Norwich Ventures Joins $3M Series A for ReThink Medical | ReThink Medical, a leading data-driven heart failure medical device and digital health company, announced today a Series A investment of $3 million led by medical device equity firm Emergent Medical Partners (EMP). EMP will lead the round w... |